Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Terumo ( (JP:4543) ) just unveiled an announcement.
Terumo Corporation has revised its full-year financial guidance for the fiscal year ending March 31, 2026, due to the yen’s depreciation and steady revenue growth. The company anticipates higher revenue and adjusted operating profit, but lower operating profit and profit attributable to owners due to acquisition-related expenses and business portfolio review costs.
The most recent analyst rating on (JP:4543) stock is a Buy with a Yen2729.00 price target. To see the full list of analyst forecasts on Terumo stock, see the JP:4543 Stock Forecast page.
More about Terumo
Terumo Corporation is a Japanese company operating in the medical devices industry, offering a range of products and services that cater to healthcare needs globally.
Average Trading Volume: 4,015,024
Technical Sentiment Signal: Hold
Current Market Cap: Yen3725.6B
Learn more about 4543 stock on TipRanks’ Stock Analysis page.